Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

12,532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation.
Park EK, Kim MS, Lee SH, Kim KH, Park JY, Kim TH, Lee IS, Woo JT, Jung JC, Shin HI, Choi JY, Kim SY. Park EK, et al. Among authors: kim th, kim ms, kim sy, kim kh. Biochem Biophys Res Commun. 2004 Dec 24;325(4):1472-80. doi: 10.1016/j.bbrc.2004.10.197. Biochem Biophys Res Commun. 2004. PMID: 15555594
A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways.
Park JY, Bae MA, Cheon HG, Kim SS, Hong JM, Kim TH, Choi JY, Kim SH, Lim J, Choi CH, Shin HI, Kim SY, Park EK. Park JY, et al. Among authors: kim ss, kim th, kim sh, kim sy. Biochem Biophys Res Commun. 2009 Jan 16;378(3):645-9. doi: 10.1016/j.bbrc.2008.11.115. Epub 2008 Dec 4. Biochem Biophys Res Commun. 2009. PMID: 19059209
Inhibitors of osteoclast formation from rhizomes of Cibotium barometz.
Cuong NX, Minh CV, Kiem PV, Huong HT, Ban NK, Nhiem NX, Tung NH, Jung JW, Kim HJ, Kim SY, Kim JA, Kim YH. Cuong NX, et al. Among authors: kim yh, kim hj, kim sy, kim ja. J Nat Prod. 2009 Sep;72(9):1673-7. doi: 10.1021/np9004097. J Nat Prod. 2009. PMID: 19739599
12,532 results
You have reached the last available page of results. Please see the User Guide for more information.